Global Rising Stars Outlook 2015: Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets, New Report Launched

Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets , approaches and biology is discovered. One field which is poised to bring a paradigm change in the way diseases are treated in the next decades is the Stem cell therapy/Regenerative Medicine space. The number of companies and products in the clinic have reached a critical mass warranting a close watch for those interested in keeping pace with the development of new medicines. The Regenerative medicine Universe is large and new companies are being added to it rapidly.  As a result we have used some filters to select a few names for a detailed coverage in our Outlook this year.

Key Criteria   for Our Selection are:-

• Uniqueness of the Technology platform and the ability to scale up commercially  in case of positive outcome of products in the  pipeline
• Pipeline and clinical data analysis
• Marketed product and commercial tie up. Robustness of the Management, financial and business model.

Products mentioned are:-

CESCA Therapeutics,OCATA Therapeutics ,Orgenesis, TiGenix, Pluristem Therapeutics ,Mesobalst Ltd, Mesobalst,Medipost, JCR Pharmaceuticals,Japan Tissue Engineering, Connexios, Bugworks, Cellworks, Tergene, Rising Stars, Drug Discovery, Regenerative Medicine, Technology Platform, Indian Pharma, Innovation, Antibiotics, Vaccines, Diabetes

Spanning over 72 pages “Global Rising Stars Outlook 2015: Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets” report covering Rising Stars in Regenerative Medicine and Stem cell based Cell Therapies-Drugs of the Future, Company Analysis, Orgenesis: Focus- Diabetes- Tricking your Liver to Make Insulin!, Mesoblast:  Leader in Regenerative Sapce in Korea- Focusing on International Markets, Medipost Co Ltd : Leader in Regenerative Space in Korea- Focusing on International Markets. This report Covered These Companies - CESCA Therapeutics,OCATA Therapeutics ,Orgenesis, TiGenix, Pluristem Therapeutics ,Mesobalst Ltd, Mesobalst,Medipost, JCR Pharmaceuticals,Japan Tissue Engineering, Connexios, Bugworks, Cellworks, Tergene.

For further information on this report, please visit- http://mrr.cm/4co

Find all Therapeutic Reports at: http://www.marketresearchreports.com/therapeutic